Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 569,299	[1]	$ 489,407	[1]
Marketable securities, available for sale	895,777	[1]	831,808	[1]
Restricted cash and cash equivalents (Alios)	0	[1]	69,983	[1]
Accounts receivable, net	85,517	[1]	143,250	[1]
Inventories	14,147	[1]	30,464	[1]
Prepaid expenses and other current assets	23,836	[1]	24,673	[1]
Total current assets	1,588,576	[1]	1,589,585	[1]
Restricted cash	130	[1]	31,934	[1]
Property and equipment, net	696,911	[1]	433,609	[1]
Intangible assets	0	[1]	663,500	[1]
Goodwill	30,992	[1]	30,992	[1]
Other assets	2,432	[1]	9,668	[1]
Total assets	2,319,041	[1]	2,759,288	[1]
Current liabilities:
Accounts payable	49,327	[1]	101,292	[1]
Accrued expenses	271,077	[1]	264,884	[1]
Deferred revenues, current portion	21,510	[1]	27,566	[1]
Accrued restructuring expense, current portion	14,286	[1]	4,758	[1]
Capital lease obligations, current portion	16,893		13,707
Income taxes payable (Alios)	0	[1]	715	[1]
Other liabilities, current portion	24,736	[1]	19,702	[1]
Total current liabilities	397,829	[1]	432,624	[1]
Deferred revenues, excluding current portion	49,459	[1]	96,242	[1]
Accrued restructuring expense, excluding current portion	14,067	[1]	18,570	[1]
Capital lease obligations, excluding current portion	48,754		15,170
Convertible senior subordinated notes (due 2015)	0	[1]	400,000	[1]
Deferred tax liability	0	[1]	280,367	[1]
Construction financing lease obligation	440,937	[1]	268,031	[1]
Other liabilities, excluding current portion	11,590	[1]	13,902	[1]
Total liabilities	962,636	[1]	1,524,906	[1]
Commitments and contingencies (Note T and Note V)		[1]		[1]
Redeemable noncontrolling interest (Alios)	0	[1]	38,530	[1]
Shareholders’ equity:
Preferred stock, $0.01 par value; 1,000,000 shares authorized; none issued and outstanding at December 31, 2013 and 2012	0	[1]	0	[1]
Common stock, $0.01 par value; 300,000,000 shares authorized at December 31, 2013 and 2012; 233,788,852 and 217,286,868 shares issued and outstanding at December 31, 2013 and 2012, respectively	2,320	[1]	2,149	[1]
Additional paid-in capital	5,321,286	[1]	4,519,448	[1]
Accumulated other comprehensive loss	(306)	[1]	(550)	[1]
Accumulated deficit	(3,966,895)	[1]	(3,521,867)	[1]
Total Vertex shareholders’ equity	1,356,405	[1]	999,180	[1]
Noncontrolling interest (Alios)	0	[1]	196,672	[1]
Total shareholders’ equity	1,356,405	[1]	1,195,852	[1]
Total liabilities and shareholders’ equity	$ 2,319,041	[1]	$ 2,759,288	[1]

[1] Amounts as of December 31, 2012 include the assets and liabilities of Vertex’s variable interest entity (“VIE”), Alios BioPharma, Inc. (“Alios”). The Company deconsolidated Alios as of December 31, 2013. Vertex’s interests and obligations with respect to the VIE’s assets and liabilities are limited to those accorded to Vertex in its agreement with Alios. See Note B, "Collaborative Arrangements," to these consolidated financial statements for amounts.